Product Information
ALPRAZOLAM INTENSOL 1 MG/ML is a generic product labeled by Hikma Pharmaceuticals USA Inc., priced at $2.8690 per ML under NDC 00054306844. Its NADAC has been published 88 times since Nov 28, 2013.
FDA first approved this application on Oct 31, 1993.
Strength
1 mg/mL
Manufacturer
Hikma Pharmaceuticals USA Inc.NDC
00054306844
Classification
Generic
Dosage Form
SOLUTION, CONCENTRATE
Route
ORAL
Effective Date
10/22/2025
Active Ingredients
ALPRAZOLAMApproval Type
Generic (ANDA)
FDA Application
ANDA074312FDA Approved
10/31/1993
On Market Since
10/31/1993
Pharmacological Classes
Price Statistics
The NADAC for ALPRAZOLAM INTENSOL 1 MG/ML has been published 88 times since Nov 28, 2013, and over the history we have for it it has risen 31.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $2.8690 per ML |
|---|---|
| All-time high | $2.8690 (Sep 30, 2026) |
| All-time low | $2.1820 (Nov 28, 2013) |
| 52-week high | $2.8690 |
| 52-week low | $2.8690 |
| Median price | $2.8690 |
| Average price | $2.6426 |
| Largest weekly change | +31.5% (Aug 20, 2025) |
| Weeks tracked | 88 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Alprazolam market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Hikma Pharmaceuticals USA Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Alprazolam market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Benzodiazepine class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of ALPRAZOLAM INTENSOL 1 MG/ML?
The current National Average Drug Acquisition Cost (NADAC) for ALPRAZOLAM INTENSOL 1 MG/ML, manufactured by Hikma Pharmaceuticals USA Inc., is $2.8690 per ML (NDC 00054306844), effective Sep 30, 2026.
How has the price of ALPRAZOLAM INTENSOL 1 MG/ML changed over time?
Over the history we have for it, the NADAC for ALPRAZOLAM INTENSOL 1 MG/ML has risen 31.5%. It has been tracked across 88 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for ALPRAZOLAM INTENSOL 1 MG/ML?
Since Nov 28, 2013, the NADAC for ALPRAZOLAM INTENSOL 1 MG/ML has ranged from a low of $2.1820 (Nov 28, 2013) to a high of $2.8690 (Sep 30, 2026), with a median of $2.8690 per ML.
Are there cheaper alternatives to ALPRAZOLAM INTENSOL 1 MG/ML?
No other NADAC-published product currently shares the active ingredient and strength of ALPRAZOLAM INTENSOL 1 MG/ML in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures ALPRAZOLAM INTENSOL 1 MG/ML?
ALPRAZOLAM INTENSOL 1 MG/ML (NDC 00054306844) is labeled by Hikma Pharmaceuticals USA Inc., and CMS classifies it as a generic product.